For Healthcare Professionals: Updates in Liquid Tumors

This video describes how to use your Jackson Pratt® drainage system. It demonstrates how to milk the tubing of your drain, empty the drainage bulb, and properly record the amount of fluid collected in the bulb. For more information about how to use and care for your Jackson Pratt drainage system, please refer to the printed materials given to you by your nurse.

This video from Memorial Sloan-Kettering Cancer Center demonstrates how to change your Foley® catheter urinary drainage bag.

Thoracic surgeon Manjit Bains talks about how he and other internationally recognized cancer experts work together to treat patients and help them return to their everyday activities.

Chief of the Thoracic Service Valerie Rusch – one of the first women to be board certified in this subspecialty – discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan-Kettering.

Babak Mehrara talks about the expertise of Memorial Sloan-Kettering plastic surgeons and how patients with breast cancer and head and neck cancer benefit from recent advances in reconstructive surgery.

Breast cancer surgeon Tari King talks about her research investigating why certain women develop breast cancer and about the long-term relationships she maintains with her patients.

Medical experts from Memorial Sloan-Kettering discuss the diagnosis and treatment of pancreatic cancer and current research initiatives.

Medical oncologist David Pfister of Memorial Sloan-Kettering explains the link between the human papillomavirus and head and neck cancer.

If you or someone you love has been affected by cancer, take ten minutes to see how the Visible Ink Writing Program empowers patients at Memorial Sloan-Kettering Cancer Center by giving voice to their individual stories.

Integrative medicine physician Gary Deng discusses complementary therapies for managing chronic pain.

Peter Allen, a pancreatic and liver cancer surgeon, talks about the specialized team of cancer experts at Memorial Sloan-Kettering and the long-term relationships he maintains with his patients.

Andrea Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.

Memorial Sloan-Kettering Cancer Center and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices. “I think that if properly applied, this has the potential of totally changing the way we conduct medicine,” says Larry Norton, Deputy Physician-in-Chief of Breast Cancer Programs at Memorial Sloan-Kettering.

Mutational profiling can improve risk stratification and inform prognostic and therapeutic decisions regarding patients with AML.

Memorial Sloan-Kettering offers a new, more patient-friendly approach – called radioactive seed localization – for surgeons to find and remove very small breast cancers.

Yuman Fong, Memorial Sloan-Kettering’s Vice Chair of Technology Development and a surgeon who treats patients with liver, bile duct, gallbladder, and pancreas diseases, talks about surgical advances that improve outcomes for patients.

James Eastham, Chief of Memorial Sloan-Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.

Integrative Medicine Service Chief Barrie Cassileth describes the program at Memorial Sloan-Kettering Cancer Center that has served as a model for similar services around the world.

Cord blood extends access to transplants for the majority of patients.

Medical oncologist Steven M. Horwitz discusses the development and impact of three new, widely used therapies for T cell lymphoma: pralatrexate, romidepsin, and brentuximab vedotin.

Chief of the Lymphoma Service Andrew Zelenetz discusses a retrospective review examining the frequency of FDG avidity across a range of lymphoma histologies.

Thrombocytopenia is a common effect of cytotoxic chemotherapy regimens in cancer patients, often necessitating reduction or delay in subsequent cycles. While the thrombocytopenia typically resolves with time, a subset of patients with chemotherapy-induced thrombocytopenia (CIT) have prolonged thrombocytopenia, of idiopathic etiology, that interferes with subsequent treatment.

Clinical Director of the Division of Hematologic Oncology Craig Moskowitz discusses positive responses of brentuximab vedotin in patients with Hodgkin lymphoma and systemic ALCL.

Medical Director of the Cytotherapy Laboratory Guenther Koehne discusses WT1-specific cellular immune responses in patients with relapsed multiple myeloma and high-risk cytogenetics.

Clinical Director of the Lymphoma Outpatient Unit Paul Hamlin discusses relationship between DLT and SAE with increasing age and comorbidities in lymphoma trials.

Medical oncologist Omar Abdel-Wahab discusses studies that assessed the functional implications of ASXL1 mutations in the hematopoietic compartment.

Medical oncologist Omar Abdel-Wahab discusses a study that validates a lower-risk prognostic scoring system’s ability to identify higher-risk MDS patients.

Neurosurgeon Mark Bilsky, MD, explains how stereotactic radiosurgery has dramatically improved outcomes for patients with spine tumors.

Clinical psychologist Wendy Lichtenthal of Memorial Sloan-Kettering discusses opportunities for personal growth after cancer treatment.

Molecular Biologist Iestyn Whitehouse discusses how the structure of chromatin is used to regulate fundamental biological processes.

Memorial Sloan-Kettering President and CEO Craig Thompson welcomes attendees to the sixth annual Major Trends in Modern Cancer Research lecture and introduces the speakers.

Nurse practitioner Megan Dunne discusses what you need to know as you prepare for life after treatment.

Physicians from Memorial Sloan-Kettering Cancer Center discuss advances in diagnosis and treatment.

Our kidney cancer experts discuss advances in diagnosis and treatment.

Stephen Solomon, an interventional radiologist at Memorial Sloan-Kettering, discusses the variety of image-guided therapies we offer patients.

Bernard Bochner discusses approaches to bladder cancer treatment.

Tony Correo, a childhood cancer survivor, talks about the value of sharing his own experiences with others who are battling cancer.

Watch the inspiring stories of three of the dozens of high school graduates who celebrated at our 2011 Pediatric Convocation ceremony.

MSKCC minimally invasive surgery expert Vincent Laudone explains how robotic surgery is used to treat prostate cancer and other urologic cancers.

Memorial Sloan-Kettering prostate cancer experts Howard Scher and Vincent Laudone explain the latest approaches.

Learn how Memorial Sloan-Kettering researchers are using genetically engineered T-cells to target cancer cells.

Memorial Sloan-Kettering Cancer Center fertility specialist Joanne Frankel Kelvin discusses the impact that cancer treatment can have on a woman’s fertility, and how patients can plan a family after treatment.

Sergio Giralt explains recent advances that have made bone and marrow stem cell transplantation safer and more effective.